AAAAAA

   
Results: 1-9 |
Results: 9
COMPARISON OF THE DISPOSITION OF ESTER PRODRUGS OF THE ANTIVIRAL AGENT 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE [PMEA] IN CACO-2 MONOLAYERS
Authors: ANNAERT P GOSSELIN G POMPON A BENZARIA S VALETTE G IMBACH JL NAESENS L HATSE S DECLERCQ E VANDENMOOTER G KINGET R AUGUSTIJNS P
Citation: P. Annaert et al., COMPARISON OF THE DISPOSITION OF ESTER PRODRUGS OF THE ANTIVIRAL AGENT 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE [PMEA] IN CACO-2 MONOLAYERS, Pharmaceutical research, 15(2), 1998, pp. 239-245
CONTROL OR GROWTH AND DIFFERENTIATION OF NORMAL HUMAN EPITHELIAL-CELLS THROUGH THE MANIPULATION OF REACTIVE NITROGEN SPECIES
Authors: TENAUD I VALETTE G BRANKA JE JARRY A SAINTEMARIE I LABOISSE C DRENO B
Citation: I. Tenaud et al., CONTROL OR GROWTH AND DIFFERENTIATION OF NORMAL HUMAN EPITHELIAL-CELLS THROUGH THE MANIPULATION OF REACTIVE NITROGEN SPECIES, Journal of investigative dermatology, 110(4), 1998, pp. 554-554
ONLINE CLEANING HPLC-UV-MS - A TOOL FOR ANALYZING NEW ANTI-HIV DRUGS IN BIOLOGICAL MEDIA
Authors: LEFEBVRE I POMPON A VALETTE G PERIGAUD C GOSSELIN G IMBACH JL
Citation: I. Lefebvre et al., ONLINE CLEANING HPLC-UV-MS - A TOOL FOR ANALYZING NEW ANTI-HIV DRUGS IN BIOLOGICAL MEDIA, LC GC, 15(9), 1997, pp. 868
THE PRONUCLEOTIDE APPROACH .3. SYNTHESIS, ANTI-HBV ACTIVITY AND STABILITY STUDIES OF THE BIS(S-PIVALOYL-2-THIOETHYL) PHOSPHOTRIESTER DERIVATIVE OF ACYCLOVIR
Authors: VALETTE G GIRARDET JL POMPON A PERIGAUD C GOSSELIN G KORBA B HANTZ O IMBACH JL
Citation: G. Valette et al., THE PRONUCLEOTIDE APPROACH .3. SYNTHESIS, ANTI-HBV ACTIVITY AND STABILITY STUDIES OF THE BIS(S-PIVALOYL-2-THIOETHYL) PHOSPHOTRIESTER DERIVATIVE OF ACYCLOVIR, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1331-1335
DECOMPOSITION PATHWAYS AND IN-VITRO HIV INHIBITORY EFFECTS OF ISODDA PRONUCLEOTIDES - TOWARD A RATIONAL APPROACH FOR INTRACELLULAR DELIVERYOF NUCLEOSIDE 5'-MONOPHOSPHATES
Authors: VALETTE G POMPON A GIRARDET JL CAPPELLACCI L FRANCHETTI P GRIFANTINI M LACOLLA P LOI AG PERIGAUD C GOSSELIN G IMBACH JL
Citation: G. Valette et al., DECOMPOSITION PATHWAYS AND IN-VITRO HIV INHIBITORY EFFECTS OF ISODDA PRONUCLEOTIDES - TOWARD A RATIONAL APPROACH FOR INTRACELLULAR DELIVERYOF NUCLEOSIDE 5'-MONOPHOSPHATES, Journal of medicinal chemistry, 39(10), 1996, pp. 1981-1990
CHARACTERIZATION OF SR 121463A, A HIGHLY POTENT AND SELECTIVE, ORALLY-ACTIVE VASOPRESSIN V-2 RECEPTOR ANTAGONIST
Authors: SERRADEILLEGAL C LACOUR C VALETTE G GARCIA G FOULON L GALINDO G BANKIR L POUZET B GUILLON G BARBERIS C CHICOT D JARD S VILAIN P GARCIA C MARTY E RAUFASTE D BROSSARD G NISATO D MAFFRAND JP LEFUR G
Citation: C. Serradeillegal et al., CHARACTERIZATION OF SR 121463A, A HIGHLY POTENT AND SELECTIVE, ORALLY-ACTIVE VASOPRESSIN V-2 RECEPTOR ANTAGONIST, The Journal of clinical investigation, 98(12), 1996, pp. 2729-2738
SR120819A, AN ORALLY-ACTIVE AND SELECTIVE NEUROPEPTIDE-Y Y1 RECEPTOR ANTAGONIST
Authors: SERRADEILLEGAL C VALETTE G ROUBY PE PELLET A OURYDONAT F BROSSARD G LESPY L MARTY E NELIAT G DECOINTET P MAFFRAND JP LEFUR G
Citation: C. Serradeillegal et al., SR120819A, AN ORALLY-ACTIVE AND SELECTIVE NEUROPEPTIDE-Y Y1 RECEPTOR ANTAGONIST, FEBS letters, 362(2), 1995, pp. 192-196
SR-27417, A NOVEL, HIGHLY POTENT AND LONG-ACTING PAF RECEPTOR ANTAGONIST
Authors: HERBERT JM BERNAT A VALETTE G CLUZEL M MAFFRAND JP
Citation: Jm. Herbert et al., SR-27417, A NOVEL, HIGHLY POTENT AND LONG-ACTING PAF RECEPTOR ANTAGONIST, Journal of lipid mediators and cell signalling, 10(1-2), 1994, pp. 149-150
BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF SR-27388, A DUAL ANTIOXIDANT AND PAF RECEPTOR ANTAGONIST
Authors: HERBERT JM FRAISSE L BACHY A VALETTE G SAVI P LAPLACE MC LASSALLE J ROCHE B LALE A KEANE PE MAFFRAND JP
Citation: Jm. Herbert et al., BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF SR-27388, A DUAL ANTIOXIDANT AND PAF RECEPTOR ANTAGONIST, Journal of lipid mediators, 8(1), 1993, pp. 31-51
Risultati: 1-9 |